• News
  • SAN DIEGO
  • Finance

Isis Pharma gets $1.1M payment from Alnylam

Isis Pharmaceuticals Inc. (Nasdaq: ISIS) said Tuesday that it will get $1.1 million from Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY) as part of Alnylam's new collaboration with Genzyme.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Isis Pharmaceuticals Inc.

Company Website

1896 Rutherford Road
Carlsbad, CA 92008

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ISIS
68.51
  -1.35  
- 1.93%
2,272,923,000
75.24
22.25

Insider Trade Data

Date Insider Shares Type Value
01/12/2015 Geary, Richard S 597 Sell $43,641
01/12/2015 Geary, Richard S 597 Sell $43,641
01/09/2015 Crooke, Stanley T 33,000 Sell $2,284,216
01/09/2015 Crooke, Stanley T 33,000 Exchange $365,760
01/09/2015 Crooke, Stanley T 33,000 Sell $2,284,216

Isis Pharmaceuticals Inc. Executive(s):

Stanley Crooke

  • Chief Executive Officer, Founder, President, Chairman

Similar Companies

NAICS - 325414 - Biological Product (except Diagnostic) Manufacturing
SIC - 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Subscribe Today!